AgriBusiness Controlled Environment Agriculture Crop Genomics Funding Round Smart Farming

Elo Life Systems Latest News: $20.5M Raised in Series A2 Financing

Elo Life Systems has raised $20.5 million in an oversubscribed Series A2 financing round, led by DCVC Bio and Novo Holdings

Key Takeaways:

  1. Elo Life Systems, a company innovating in food ingredients, has completed an oversubscribed Series A2 financing round, raising $20.5 million.
  2. The funding round was co-led by DCVC Bio and Novo Holdings, with participation from Hanwha Next Generation Opportunity Fund, AccelR8, and Alexandria Venture Investments.
  3. Elo Life Systems plans to use this funding to scale and commercialize its monk-fruit-derived sweetener, expand its molecular-farming pipeline, and enhance crop protection efforts, including saving the banana from extinction.
  4. The company’s approach combines molecular farming with sustainability goals to produce environmentally friendly and cost-effective ingredients.
  5. Elo Life Systems is set to launch its first product, a natural sweetener 300 times sweeter than sugar without calories, in 2026.

Reimagining the Future of Food

Elo Life Systems has announced a significant milestone in transforming the food industry. After completing an oversubscribed Series A2 financing round, the company has raised $20.5 million. This latest achievement brings Elo’s total funding to $45 million. The fundraising round was led jointly by DCVC Bio and Novo Holdings, indicating strong investor confidence in Elo’s vision and strategy. Additional investors include Hanwha Next Generation Opportunity Fund, AccelR8, and Alexandria Venture Investments.

Scaling Up Innovation

Elo CEO Todd Rands emphasized the company’s mission to make food more delicious, healthy, and planet-friendly. The new funding will accelerate production scaling and launch their first product in 2026. Their innovative approach involves using crops as biofactories for hard-to-harvest ingredients, which promises to revolutionize how we produce and consume food.

Molecular Farming: A Game Changer

Stephen Van Helden of Novo Holdings US highlighted Elo’s potential to meet global food needs while minimizing environmental impact. Elo’s molecular farming platform is a critical component in this endeavor, enabling the production of sought-after ingredients at a reduced cost and ecological footprint.

A Sweet Future Ahead

Elo’s first product, a natural sweetener derived from monk fruit, is set to be a transformative addition to the food industry. Being 300 times sweeter than sugar and calorie-free, this sweetener holds promise for reducing sugar and artificial sweeteners in a wide array of products. Kiersten Stead from DCVC Bio pointed out the potential health benefits and reduced chronic disease burden associated with this innovation.

Beyond Sweeteners

Elo’s ambitions go beyond sweeteners. They are actively involved in protecting staple crops like bananas from disease and climate change. In collaboration with Dole, Elo has developed a fungal-resistant Cavendish banana, currently in field trials in Latin America, aiming to save this vital food source from extinction. This financing round marks a significant step for Elo Life Systems in its pursuit of creating a more sustainable and healthy future for food production and consumption.


Elo Life Systems Recent News

Elo Life Systems Banks a $24.5M Series A (2023/02/16)

Elo Life Systems has successfully raised $24.5 million in a Series A financing round, with AccelR8, Novo Holdings, and DCVC Bio leading the investment. The company plans to accelerate the development of its innovative, calorie-free sweeteners that are 300 times sweeter than sugar, derived from locally grown crops like watermelons, reducing environmental impact and costs compared to traditional monk-fruit sweeteners. With the completion of significant product development milestones, including advancements in watermelon-based sweeteners and fungal-resistant Cavendish bananas, Elo is preparing for field trials in the U.S. and Central America. The company anticipates a Series B round for further scaling and commercialization. Additionally, the appointment of Joan Braca as its first independent director underscores Elo’s commitment to diversifying its leadership team and enhancing its global presence in the healthy ingredient market.

Image provided by Elo Life Systems

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply

X

Discover more from iGrow News

Subscribe now to keep reading and get access to the full archive.

Continue reading